Literature DB >> 9235796

[Arterial hypertension and blood pressure profile in patients with Williams-Beuren syndrome].

A Wessel1, R Motz, R Pankau, J H Bürsch.   

Abstract

The prevalence of hypertension and the diurnal blood pressure pattern were investigated in patients with Williams-Beuren syndrome (WBS) by blood pressure measurements in 142 children, adolescents, and young adults (female n = 62, male n = 80; median age 6.5 years (0.1-34.3 years)) and evaluation of ambulatory blood pressure data from 45 patients (female n = 21, male n = 24; median age 7.8 years (1-23.8 years)). Measurements revealed systolic hypertension in 46.5% of 142 patients, diastolic hypertension occurred in 36.6% (i.e. actual pressure > 95 percentile). According to the ambulatory data 42.2% of 45 patients had hypertension (mean arterial pressure > normal + 2SD). The nocturnal decline of the blood pressure was normal in hypertensive patients but reduced in normotensives (p < 0.01 vs normals). Males were more often hypertensive than females (46% vs 38%). Hypertensives had a higher body mass index than normotensives (19.5 vs 16.6 kg/m2, p < 0.05). In normo- and hypertensive WBS patients mean heart rates were elevated during day- and nighttime (p < 0.02 vs normals) the latter due to a reduced nocturnal decline. The prevalence of hypertension in WBS patients amounts to about 40%, thus being four- to eight-fold in comparison to healthy young adults or children. The diurnal blood pressure pattern and the elevated heart rates indicate that an increased arterial stiffness due to the vascular disease in the WBS and augmented sympathetic activity might play a role in the genesis of hypertension. Thus, effective antihypertensive treatment is likely to become difficult. From our experience beta-blocking agents are often successful in hypertensive WBS patients.

Entities:  

Mesh:

Year:  1997        PMID: 9235796     DOI: 10.1007/s003920050056

Source DB:  PubMed          Journal:  Z Kardiol        ISSN: 0300-5860


  7 in total

1.  Mechanical properties of the common carotid artery in Williams syndrome.

Authors:  Y Aggoun; D Sidi; B I Levy; S Lyonnet; J Kachaner; D Bonnet
Journal:  Heart       Date:  2000-09       Impact factor: 5.994

2.  Echocardiographic findings in patients with Williams-Beuren syndrome.

Authors:  Dora Scheiber; Gyorgy Fekete; Zoltan Urban; Ildiko Tarjan; Gergely Balaton; Lajos Kosa; Katalin Nagy; Zoltan Vajo
Journal:  Wien Klin Wochenschr       Date:  2006-09       Impact factor: 1.704

Review 3.  Mechanisms and treatment of cardiovascular disease in Williams-Beuren syndrome.

Authors:  Barbara R Pober; Mark Johnson; Zsolt Urban
Journal:  J Clin Invest       Date:  2008-05       Impact factor: 14.808

4.  Elastin haploinsufficiency induces alternative aging processes in the aorta.

Authors:  Mylène Pezet; Marie-Paule Jacob; Brigitte Escoubet; Dealba Gheduzzi; Emmanuelle Tillet; Pascale Perret; Philippe Huber; Daniela Quaglino; Roger Vranckx; Dean Y Li; Barry Starcher; Walter A Boyle; Robert P Mecham; Gilles Faury
Journal:  Rejuvenation Res       Date:  2008-02       Impact factor: 4.663

5.  Reduction of NADPH-oxidase activity ameliorates the cardiovascular phenotype in a mouse model of Williams-Beuren Syndrome.

Authors:  Victoria Campuzano; Maria Segura-Puimedon; Verena Terrado; Carolina Sánchez-Rodríguez; Mathilde Coustets; Mauricio Menacho-Márquez; Julián Nevado; Xosé R Bustelo; Uta Francke; Luis A Pérez-Jurado
Journal:  PLoS Genet       Date:  2012-02-02       Impact factor: 5.917

6.  A Diagnosis to Consider in an Adult Patient with Facial Features and Intellectual Disability: Williams Syndrome.

Authors:  Özlem Akgün Doğan; Pelin Özlem Şimşek Kiper; Gülen Eda Utine; Mehmet Alikaşifoğlu; Koray Boduroğlu
Journal:  Korean J Fam Med       Date:  2017-03-22

7.  Minoxidil versus placebo in the treatment of arterial wall hypertrophy in children with Williams Beuren Syndrome: a randomized controlled trial.

Authors:  Behrouz Kassai; Philippe Bouyé; Brigitte Gilbert-Dussardier; François Godart; Jean-Benoit Thambo; Massimiliano Rossi; Pierre Cochat; Pierre Chirossel; Stephane Luong; André Serusclat; Isabelle Canterino; Catherine Mercier; Muriel Rabilloud; Christine Pivot; Fabrice Pirot; Tiphanie Ginhoux; Stéphanie Coopman; Guillaume Grenet; François Gueyffier; Sylvie Di-Fillippo; Aurélia Bertholet-Thomas
Journal:  BMC Pediatr       Date:  2019-05-28       Impact factor: 2.125

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.